{"id":"https://openalex.org/W3130104363","doi":"https://doi.org/10.1093/abt/tbab003","title":"Optimization of therapeutic antibodies","display_name":"Optimization of therapeutic antibodies","alternate_titles":[],"publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3130104363","doi":"https://doi.org/10.1093/abt/tbab003","mag":"3130104363","pmid":"https://pubmed.ncbi.nlm.nih.gov/33928235","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7944496"},"language":"en","primary_location":{"id":"doi:10.1093/abt/tbab003","doi":"https://doi.org/10.1093/abt/tbab003","is_oa":true,"landing_page_url":"https://doi.org/10.1093/abt/tbab003","pdf_url":"https://academic.oup.com/abt/article-pdf/4/1/45/36463114/tbab003.pdf","source":{"id":"https://openalex.org/S4210177059","display_name":"Antibody Therapeutics","issn_l":"2516-4236","issn":["2516-4236"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibody Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3130104363"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/abt/article-pdf/4/1/45/36463114/tbab003.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079021767","display_name":"Bo Wang","orcid":"https://orcid.org/0000-0002-8560-9071","observed_orcids":["https://orcid.org/0000-0002-8560-9071"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bo Wang","raw_affiliation_strings":["Ab Studio, Inc. Hayward, CA 94545, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ab Studio, Inc. Hayward, CA 94545, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019883404","display_name":"Sachith Gallolu Kankanamalage","orcid":"https://orcid.org/0000-0001-6559-686X","observed_orcids":["https://orcid.org/0000-0001-6559-686X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sachith Gallolu Kankanamalage","raw_affiliation_strings":["Ab Studio, Inc. Hayward, CA 94545, USA"],"raw_orcid":"https://orcid.org/0000-0001-6559-686X","affiliations":[{"raw_affiliation_string":"Ab Studio, Inc. Hayward, CA 94545, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100743206","display_name":"Jianbo Dong","orcid":"https://orcid.org/0000-0003-0939-8943","observed_orcids":["https://orcid.org/0000-0003-0939-8943"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jianbo Dong","raw_affiliation_strings":["Ab Studio, Inc. Hayward, CA 94545, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ab Studio, Inc. Hayward, CA 94545, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100320032","display_name":"Yue Liu","orcid":"https://orcid.org/0000-0001-9626-1173","observed_orcids":["https://orcid.org/0000-0001-9626-1173"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yue Liu","raw_affiliation_strings":["Ab Studio, Inc. Hayward, CA 94545, USA","Ab Therapeutics, Inc. Hayward, CA 94545, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ab Studio, Inc. Hayward, CA 94545, USA","institution_ids":[]},{"raw_affiliation_string":"Ab Therapeutics, Inc. Hayward, CA 94545, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5100320032"],"corresponding_institution_ids":[],"apc_list":{"value":2625,"currency":"USD","value_usd":2625},"apc_paid":{"value":2625,"currency":"USD","value_usd":2625},"fwci":0.8683,"has_fulltext":true,"cited_by_count":76,"citation_normalized_percentile":{"value":0.68622967,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"4","issue":"1","first_page":"45","last_page":"54"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.8730000257492065},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.8500000238418579},{"id":"https://openalex.org/keywords/antibody-optimization","display_name":"antibody optimization","score":0.753000020980835},{"id":"https://openalex.org/keywords/display-technology","display_name":"display technology","score":0.7590000033378601},{"id":"https://openalex.org/keywords/computer-aided-design","display_name":"computer-aided design","score":0.921999990940094},{"id":"https://openalex.org/keywords/site-directed-mutagenesis","display_name":"site-directed mutagenesis","score":0.9160000085830688},{"id":"https://openalex.org/keywords/antigen-binding-affinity","display_name":"antigen binding affinity","score":0.9580000042915344},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7590000033378601},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9779999852180481},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9800000190734863}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8733004331588745},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6833140254020691},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5232100486755371},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5047568082809448},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4561542570590973},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.4451177716255188},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.41293007135391235},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31251853704452515},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3122272491455078},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2729986310005188},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23778918385505676},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18966978788375854},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11083972454071045},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.059947848320007324}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/abt/tbab003","doi":"https://doi.org/10.1093/abt/tbab003","is_oa":true,"landing_page_url":"https://doi.org/10.1093/abt/tbab003","pdf_url":"https://academic.oup.com/abt/article-pdf/4/1/45/36463114/tbab003.pdf","source":{"id":"https://openalex.org/S4210177059","display_name":"Antibody Therapeutics","issn_l":"2516-4236","issn":["2516-4236"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibody Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7944496","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7944496/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antib Ther","raw_type":"Text"},{"id":"pmid:33928235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33928235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibody therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/abt/tbab003","doi":"https://doi.org/10.1093/abt/tbab003","is_oa":true,"landing_page_url":"https://doi.org/10.1093/abt/tbab003","pdf_url":"https://academic.oup.com/abt/article-pdf/4/1/45/36463114/tbab003.pdf","source":{"id":"https://openalex.org/S4210177059","display_name":"Antibody Therapeutics","issn_l":"2516-4236","issn":["2516-4236"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibody Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.766700029373169}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3130104363.pdf","grobid_xml":"https://content.openalex.org/works/W3130104363.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W1529809181","https://openalex.org/W1595328377","https://openalex.org/W1902650446","https://openalex.org/W1903287340","https://openalex.org/W1943037631","https://openalex.org/W1968037422","https://openalex.org/W1969482494","https://openalex.org/W1972438493","https://openalex.org/W1976287795","https://openalex.org/W1976394313","https://openalex.org/W1976681671","https://openalex.org/W1979626824","https://openalex.org/W1982696245","https://openalex.org/W1986864699","https://openalex.org/W1996045402","https://openalex.org/W2000784356","https://openalex.org/W2014680690","https://openalex.org/W2017854516","https://openalex.org/W2022505591","https://openalex.org/W2028033239","https://openalex.org/W2030085576","https://openalex.org/W2033588702","https://openalex.org/W2035070408","https://openalex.org/W2038319340","https://openalex.org/W2039870425","https://openalex.org/W2044098466","https://openalex.org/W2045608551","https://openalex.org/W2055530646","https://openalex.org/W2060204419","https://openalex.org/W2071425823","https://openalex.org/W2072546632","https://openalex.org/W2075097399","https://openalex.org/W2078111332","https://openalex.org/W2083028331","https://openalex.org/W2084136419","https://openalex.org/W2085729628","https://openalex.org/W2089531740","https://openalex.org/W2089644524","https://openalex.org/W2090618368","https://openalex.org/W2094445987","https://openalex.org/W2098154603","https://openalex.org/W2104198642","https://openalex.org/W2104943097","https://openalex.org/W2104983755","https://openalex.org/W2107214337","https://openalex.org/W2109860639","https://openalex.org/W2116644153","https://openalex.org/W2130611069","https://openalex.org/W2132900185","https://openalex.org/W2136007354","https://openalex.org/W2137769328","https://openalex.org/W2141301556","https://openalex.org/W2143562636","https://openalex.org/W2143624794","https://openalex.org/W2148090354","https://openalex.org/W2149725620","https://openalex.org/W2168313542","https://openalex.org/W2169479166","https://openalex.org/W2298166996","https://openalex.org/W2314467531","https://openalex.org/W2330599445","https://openalex.org/W2419331637","https://openalex.org/W2606230253","https://openalex.org/W2904665596","https://openalex.org/W2922522738","https://openalex.org/W2942512732","https://openalex.org/W3103755394"],"related_works":["https://openalex.org/W4254682436","https://openalex.org/W2050754173","https://openalex.org/W2948074633","https://openalex.org/W2411977960","https://openalex.org/W2805822355","https://openalex.org/W2105405216","https://openalex.org/W2112848215","https://openalex.org/W2034361540","https://openalex.org/W2385804041","https://openalex.org/W2504433076"],"abstract_inverted_index":{"In":[0],"this":[1],"review,":[2],"we":[3],"have":[4],"summarized":[5],"the":[6,30,38,70],"current":[7],"landscape":[8],"of":[9,29,40,72],"therapeutic":[10,31,80],"antibody":[11,32],"optimization":[12,71],"for":[13],"successful":[14],"development.":[15],"By":[16],"engineering":[17],"antibodies":[18],"with":[19,37],"display":[20],"technology,":[21],"computer-aided":[22],"design":[23],"and":[24,45,53,58,61],"site":[25],"mutagenesis,":[26],"various":[27],"properties":[28,48,75],"candidates":[33],"can":[34],"be":[35],"improved":[36],"purpose":[39],"enhancing":[41],"their":[42],"safety,":[43],"efficacy":[44],"developability.":[46],"These":[47],"include":[49],"antigen":[50],"binding":[51],"affinity":[52],"specificity,":[54],"biological":[55],"efficacy,":[56],"pharmacokinetics":[57],"pharmacodynamics,":[59],"immunogenicity":[60],"physicochemical":[62],"developability":[63],"features.":[64],"A":[65],"best-in-class":[66],"strategy":[67],"may":[68],"require":[69],"all":[73],"these":[74],"to":[76],"generate":[77],"a":[78],"good":[79],"antibody.":[81]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3130104363","counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-03-01T00:00:00"}
